<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7135364\results\search\drugs\results.xml">
  <result pre="due to coronaviruses. Several pre-existing and potential drug candidates, including" exact="chloroquine" post="and remdesivir, have been considered [10], [11], [12]. The"/>
  <result pre="fleximer analogues [12]. Remdesivir (GS-5734), the phosphoramidate prodrug of an" exact="adenosine" post="C‑nucleoside [13], has a similar structure to tenofovir alafenamide,"/>
  <result pre="of an adenosine C‑nucleoside [13], has a similar structure to" exact="tenofovir" post="alafenamide, which is a nucleotide analogue of adenosine 5-monophosphate"/>
  <result pre="structure to tenofovir alafenamide, which is a nucleotide analogue of" exact="adenosine" post="5-monophosphate with antiviral activity against hepatitis B virus and"/>
  <result pre="demonstrated that nucleoside triphosphate works as an incorporation competitor with" exact="adenosine" post="triphosphate, confuses viral RdRp, acts as a delayed RNA"/>
  <result pre="the viral polymerase and the proofreading exoribonucleasemBio9201810.1128/mBio.00221-18pii: e00221-18 18WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 </snippets>
</snippetsTree>
